FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based sp

BenzingaApr 25 20:02

FibroBiologics Plans to Collaborate With Charles River to Manufacture Fibroblast-based Spheroids

HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics") and Charles River Laboratories ("Charles River"), a highly respected, global provider of drug discovery,

GlobeNewswireApr 25 20:00

Charles River Shares Are Trading Higher in Possible Sympathy With Danaher, Which Reported Better-than-expected Q1 Financial Results.

Charles River Shares Are Trading Higher in Possible Sympathy With Danaher, Which Reported Better-than-expected Q1 Financial Results.

BenzingaApr 23 20:47

Charles River Associates (CRA) to Host First-Quarter Fiscal 2024 Financial Results Conference Call on May 2

Conference Call to be Webcast Live at 10:00 a.m. ET Charles River Associates (NASDAQ:CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company

BusinesswireApr 23 20:30

Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally

Company marks significant progress towards climate goals, reaching the milestone considerably ahead of scheduleWILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #LIFEatCRL--Charles River Laboratories Internati

BusinesswireApr 22 20:00

Here's Why You Should Retain Charles River (CRL) Stock Now

Yahoo FinanceApr 16 23:50